Literatur
Launch-Pressekonferenz „Hydromorphon Aristo® long. Moderne Schmerztherapie: lang anhaltend, bewährt, bezahlbar“; Berlin, Januar 2014 (Veranstalter: Aristo Pharma)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bruhn, C. Retardiertes orales Hydromorphon. MMW - Fortschritte der Medizin 156, 72 (2014). https://doi.org/10.1007/s15006-014-3037-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-014-3037-3